A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Observation to Treat Vision Loss Associated With Macular Edema Secondary to Central Retinal Vein Occlusion
Indexed incrossrefpubmed
Abstract
Objective
To compare the efficacy and safety of 1-mg and 4-mg doses of preservative-free intravitreal triamcinolone with observation for eyes with vision loss associated with macular edema secondary to perfused central retinal vein occlusion (CRVO).
Methods
Multicenter, randomized, clinical trial of 271 participants. MAIN OUTCOME MEASURE: Gain in visual acuity letter score of 15 or more from baseline to month 12.
Citation impact
677
total citations
- FWCI
- 61.81
- Percentile
- 100%
- References
- 79
Citations per year
Authors
10Topics & keywords
Keywords
- Medicine
- Central retinal vein occlusion
- Macular edema
- Triamcinolone acetonide
- Randomized controlled trial
- Branch retinal vein occlusion
- Ophthalmology
- Occlusion
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.